Restricted Myogenic Potential of Mesenchymal Stromal Cells IsolatedFrom Umbilical Cord
Authors: Grabowska, Iwona; Brzoska, Edyta; Gawrysiak, Agnieszka; Streminska, Wladyslawa; Moraczewski, Jerzy; Polanski, Zbigniew; Hoser, Grazyna; Kawiak, Jerzy; Machaj, Eugeniusz K.; Pojda, Zygmunt; Ciemerych, Maria A.
Source: Cell Transplantation, Volume 21, Number 8, 2012 , pp. 1711-1726(16)
Publisher: Cognizant Communication Corporation
Abstract:Nonhematopoietic cord blood cells and mesenchymal cells of umbilical cord Wharton's jelly have been shown to be able to differentiate into various cell types. Thus, as they are readily available and do not raise any ethical issues, these cells are considered to be a potential source of material that can be used in regenerative medicine. In our previous study, we tested the potential of whole mononucleated fraction of human umbilical cord blood cells and showed that they are able to participate in the regeneration of injured mouse skeletal muscle. In the current study, we focused at the umbilical cord mesenchymal stromal cells isolated from Wharton's jelly. We documented that limited fraction of these cells express markers of pluripotent and myogenic cells. Moreover, they are able to undergo myogenic differentiation in vitro, as proved by coculture with C2C12 myoblasts. They also colonize injured skeletal muscle and, with low frequency, participate in the formation of new muscle fibers. Pretreatment of Wharton's jelly mesenchymal stromal cells with SDF-1 has no impact on their incorporation into regenerating muscle fibers but significantly increased muscle mass. As a result, transplantation of mesenchymal stromal cells enhances the skeletal muscle regeneration.
Document Type: Research Article
Publication date: 2012-08-01
- Cell Transplantation publishes original, peer-reviewed research and review articles on the subject of cell transplantation and its application to human diseases. To ensure high-quality contributions from all areas of transplantation, separate section editors and editorial boards have been established. Articles deal with a wide range of topics including physiological, medical, preclinical, tissue engineering, and device-oriented aspects of transplantation of nervous system, endocrine, growth factor-secreting, bone marrow, epithelial, endothelial, and genetically engineered cells, among others. Basic clinical studies and immunological research papers are also featured. To provide complete coverage of this revolutionary field, Cell Transplantation will report on relevant technological advances, and ethical and regulatory considerations of cell transplants. Cell Transplantation is now an Open Access journal starting with volume 18 in 2009, and therefore there will be an inexpensive publication charge, which is dependent on the number of pages, in addition to the charge for color figures. This will allow work to be disseminated to a wider audience and also entitle the corresponding author to a free PDF, as well as prepublication of an unedited version of the manuscript.
- In this: publication
- By this: publisher
- In this Subject: Anatomy & Physiology , Biology , Biotechnology , Pharmacology , Surgery
- By this author: Grabowska, Iwona ; Brzoska, Edyta ; Gawrysiak, Agnieszka ; Streminska, Wladyslawa ; Moraczewski, Jerzy ; Polanski, Zbigniew ; Hoser, Grazyna ; Kawiak, Jerzy ; Machaj, Eugeniusz K. ; Pojda, Zygmunt ; Ciemerych, Maria A.